Fundraise led by Sofinnova Partners, F-Prime Capital, Digitalis Ventures and Cambridge Innovation Capital with participation from Sanofi Ventures and the University of Cambridge Venture Fund Unique transgenic mouse platform harnesses natural power of T cells Read More
Tags :Sofinnova Partners
Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research Horizons Ventures and Sofinnova Partners Co-Lead Investment in Market-leadingLife Sciences Software Company That Transforms the Way Scientists Automate Read More
Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group Cambridge, UK, 28 October 2021: Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary Read More